{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:36:37Z","timestamp":1792798597208,"version":"4.5.0"},"reference-count":47,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T00:00:00Z","timestamp":1632268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Upregulation of metastasis-associated lung adenocarcinoma transcript 1 (MALAT1, also known as nuclear-enriched abundant transcript 2 (NEAT2) or LINC00047) was found in various solid tumors, including epithelial ovarian cancer (EOC). MALAT1 is a long noncoding (lnc)RNA that regulates many functional signaling pathways, including tumorigenesis. Herein, we observed the consistent upregulation of MALAT1 in MYST4-overexpressing cell lines, while MALAT1 was frequently found to be upregulated in various types of clinical carcinoma tissues, especially EOC. To further investigate the lncRNA MALAT1 in EOC progression, the transduced overexpression of MALAT1 in EOC cell lines and cancer-associated fibroblasts (CAFs) was employed. We found that MALAT1 overexpression in EOC cell lines significantly increased drug resistance, cell migration, and invasion. Furthermore, the concomitant overexpression of MALAT1 in EOC cells and CAFs dramatically increased EOC cell invasion. Accordingly, a mechanistic investigation of MALAT1 overexpression in EOC cells showed that expressions of the cytokines interleukin (IL)-1\u03b2 and p-P38\/p-NF\u03baB\/Cox2\/prostaglandin E2 (PGE2) signaling were significantly increased, which stimulated inflammatory responses, whereas cell apoptosis was inhibited due to increased Bcl-2 levels and reduced Caspase3 levels. After MALAT1 was overexpressed in EOC cells, and the cyclin D1, p-PI3K, and p-Akt expressions increased, suggesting the promotion of tumor cell proliferation, while increased zinc finger E-box-binding homeobox-2 (ZEB2), yes-associated protein (YAP), and vimentin expression with E-cadherin downregulation indicated the enhancement of the epithelial-to-mesenchymal transition (EMT) in terms of metastasis, thereby triggering EOC progression. Together, our findings demonstrate how MALAT1 overexpression facilitates an oncogenic function through inhibiting tumor cell apoptosis, combined with increasing tumor cell inflammation, proliferation, and invasion in the EOC tumor microenvironment. MALAT1 is thus a potential diagnostic marker and therapeutic for this malignancy.<\/jats:p>","DOI":"10.3390\/ijms221910201","type":"journal-article","created":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T22:24:13Z","timestamp":1632695053000},"page":"10201","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["LncRNA MALAT1 Facilitates Ovarian Cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment"],"prefix":"10.3390","volume":"22","author":[{"given":"Tsui-Lien","family":"Mao","sequence":"first","affiliation":[{"name":"Department of Pathology, College of Medicine, National Taiwan University, Taipei 10002, Taiwan"},{"name":"Department of Pathology, National Taiwan University Hospital, Taipei 10002, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Huei","family":"Fan","sequence":"additional","affiliation":[{"name":"School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhlanhla","family":"Dlamini","sequence":"additional","affiliation":[{"name":"PhD Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9574-0305","authenticated-orcid":false,"given":"Chao-Lien","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan"},{"name":"PhD Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s10753-019-00995-2","article-title":"Targeting of IL-6-Relevant Long Noncoding RNA Profiles in Inflammatory and Tumorous Disease","volume":"42","author":"Zhang","year":"2019","journal-title":"Inflammation"},{"key":"ref_2","first-page":"5335","article-title":"lncRNA MALAT1 overexpression promotes proliferation, migration and invasion of gastric cancer by activating the PI3K\/AKT pathway","volume":"17","author":"Zhu","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopha.2016.05.044","article-title":"Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients","volume":"83","author":"Huang","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s42003-019-0741-7","article-title":"LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis","volume":"3","author":"Feuerbach","year":"2020","journal-title":"Commun. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.2147\/CMAR.S267355","article-title":"LncRNA MALAT1 Promotes Survival of Epithelial Ovarian Cancer Cells by Downregulating miR-145-5p","volume":"12","author":"Wang","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/j.celrep.2017.05.006","article-title":"Identification and Characterization of a Class of MALAT1-like Genomic Loci","volume":"19","author":"Zhang","year":"2017","journal-title":"Cell Rep."},{"key":"ref_7","first-page":"2644","article-title":"MALAT1 affects ovarian cancer cell behavior and patient survival","volume":"39","author":"Lin","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.drudis.2018.04.010","article-title":"Role of lncRNAs in ovarian cancer: Defining new biomarkers for therapeutic purposes","volume":"23","author":"Tripathi","year":"2018","journal-title":"Drug Discov. Today"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhang, J., Han, C., Song, K., Chen, W., Ungerleider, N., Yao, L., Ma, W., and Wu, T. (2020). The long-noncoding RNA MALAT1 regulates TGF-\u03b2\/Smad signaling through formation of a lncRNA-protein complex with Smads, SETD2 and PPM1A in hepatic cells. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0228160"},{"key":"ref_10","first-page":"15903","article-title":"MALAT1 is an oncogenic long non-coding RNA associated with tumor invasion in non-small cell lung cancer regulated by DNA methylation","volume":"8","author":"Guo","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1007\/s13277-014-2850-8","article-title":"Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer","volume":"36","author":"Pang","year":"2015","journal-title":"Tumor Biol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Paniri, A., and Akhavan-Niaki, H. (2020). Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation. Life Sci., 257.","DOI":"10.1016\/j.lfs.2020.118114"},{"key":"ref_13","first-page":"431","article-title":"The overexpression of MYST4 in human solid tumors is associated with increased aggressiveness and decreased overall survival","volume":"12","author":"Liu","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_14","first-page":"19","article-title":"MALAT1: A long non-coding RNA highly associated with human cancers","volume":"16","author":"Zhao","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_15","first-page":"3703","article-title":"Long non-coding RNA MALAT1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt\/\u03b2-catenin signaling pathway","volume":"22","author":"Guo","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Braga, E.A., Fridman, M.V., Moscovtsev, A.A., Filippova, E.A., Dmitriev, A.A., and Kushlinskii, N.E. (2020). LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: CeRNA and Alternative Mechanisms. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228855"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1016\/j.febslet.2013.07.048","article-title":"MALAT-1 interacts with hnRNP C in cell cycle regulation","volume":"587","author":"Yang","year":"2013","journal-title":"FEBS Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.4049\/jimmunol.1900940","article-title":"Malat1 Suppresses Immunity to Infection through Promoting Expression of Maf and IL-10 in Th Cells","volume":"204","author":"Hewitson","year":"2020","journal-title":"J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/03008207.2018.1439480","article-title":"Knockdown of LncRNA MALAT1 contributes to the suppression of inflammatory responses by up-regulating miR-146a in LPS-induced acute lung injury","volume":"59","author":"Dai","year":"2018","journal-title":"Connect. Tissue Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.abb.2018.04.016","article-title":"BML-111 alleviates acute lung injury through regulating the expression of lncRNA MALAT1","volume":"649","author":"Li","year":"2018","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1523\/JNEUROSCI.3389-16.2017","article-title":"Long Noncoding RNA Malat1 Regulates Cerebrovascular Pathologies in Ischemic Stroke","volume":"37","author":"Zhang","year":"2017","journal-title":"J. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.omtn.2019.10.028","article-title":"lncRNA MALAT1 Accelerates Skeletal Muscle Cell Apoptosis and Inflammatory Response in Sepsis by Decreasing BRCA1 Expression by Recruiting EZH2","volume":"19","author":"Yong","year":"2020","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/cvr\/cvy202","article-title":"Immune system-mediated atherosclerosis caused by deficiency of long non-coding RNA MALAT1 in ApoE-\/-mice","volume":"115","author":"Gast","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10020-018-0050-5","article-title":"The effects of lncRNA MALAT1 on proliferation, invasion and migration in colorectal cancer through regulating SOX9","volume":"24","author":"Xu","year":"2018","journal-title":"Mol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bbrc.2016.02.102","article-title":"MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42","volume":"472","author":"Chou","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-019-1598-x","article-title":"MALAT1 regulates the transcriptional and translational levels of proto-oncogene RUNX2 in colorectal cancer metastasis","volume":"10","author":"Ji","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/OTT.S112686","article-title":"Long noncoding RNA MALAT1-regulated microRNA 506 modulates ovarian cancer growth by targeting iASPP","volume":"10","author":"Lei","year":"2016","journal-title":"OncoTargets Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.1096\/fj.201800495RR","article-title":"miR-211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma","volume":"32","author":"Tao","year":"2018","journal-title":"FASEB J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.12659\/MSM.922012","article-title":"The Long Non-Coding RNA MALAT1 Enhances Ovarian Cancer Cell Stemness by Inhibiting YAP Translocation from Nucleus to Cytoplasm","volume":"26","author":"Wu","year":"2020","journal-title":"Med Sci. Monit."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yexcr.2018.03.014","article-title":"Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway","volume":"366","author":"Bai","year":"2018","journal-title":"Exp. Cell Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/s41588-018-0252-3","article-title":"Long noncoding RNA MALAT1 suppresses breast cancer metastasis","volume":"50","author":"Kim","year":"2018","journal-title":"Nat. Genet."},{"key":"ref_32","first-page":"485","article-title":"Cancer Screening in Women. Obstet. Gynecol","volume":"46","author":"Vogell","year":"2019","journal-title":"Clin. N. Am."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.2147\/OTT.S242300","article-title":"Long Noncoding RNA MALAT1 Promotes the Development of Colon Cancer by Regulating miR-101-3p\/STC1 Axis","volume":"13","author":"Luan","year":"2020","journal-title":"OncoTargets Ther."},{"key":"ref_34","first-page":"6977","article-title":"LncRNA MALAT-1 promotes growth and metastasis of epithelial ovarian cancer via sponging microrna-22","volume":"12","author":"Pei","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Wei, S., Wang, K., Huang, X., Zhao, Z., and Zhao, Z. (2019). LncRNA MALAT1 contributes to non-small cell lung cancer progression via modulating miR-200a-3p\/programmed death-ligand 1 axis. Int. J. Immunopathol. Pharmacol., 33.","DOI":"10.1177\/2058738419859699"},{"key":"ref_36","first-page":"419","article-title":"Long non-coding RNA MALAT1 interaction with miR-429 regulates the proliferation and EMT of lung adenocarcinoma cells through RhoA","volume":"12","author":"Xiao","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"11213","DOI":"10.1074\/jbc.RA118.006889","article-title":"Hypoxia induces cancer cell-specific chromatin interactions and increases MALAT1 expression in breast cancer cells","volume":"294","author":"Stone","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41419-019-1620-3","article-title":"MALAT1 regulates miR-34a expression in melanoma cells","volume":"10","author":"Li","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/imm.12698","article-title":"Long non-coding RNA: A versatile regulator of the nuclear factor-\u03baB signalling circuit","volume":"150","author":"Mao","year":"2017","journal-title":"Immunology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1158\/0008-5472.CAN-14-2931","article-title":"Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205","volume":"75","author":"Hirata","year":"2015","journal-title":"Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/1873-3468.12315","article-title":"The long noncoding RNA MALAT1 regulates the lipopolysaccharide-induced inflammatory response through its interaction with NF-kappaB","volume":"590","author":"Zhao","year":"2016","journal-title":"FEBS Lett."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Wu, J., Zhang, H., Zheng, Y., Jin, X., Liu, M., Li, S., Zhao, Q., Liu, X., Wang, Y., and Shi, M. (2018). The Long Noncoding RNA MALAT1 Induces Tolerogenic Dendritic Cells and Regulatory T Cells via miR155\/Dendritic Cell-Specific Intercellular Adhesion Molecule-3 Grabbing Nonintegrin\/IL10 Axis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01847"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1002\/jcb.25927","article-title":"Long Non-Coding RNA MALAT1 Promotes Proliferation, Angiogenesis, and Immunosuppressive Properties of Mesenchymal Stem Cells by Inducing VEGF and IDO","volume":"118","author":"Li","year":"2017","journal-title":"J. Cell. Biochem."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Liu, C.L., Chen, Y.J., Fan, M.H., Liao, Y.J., and Mao, T.L. (2020). Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186467"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.3892\/ol.2016.4435","article-title":"Inhibition of the long non-coding RNA MALAT1 suppresses tumorigenicity and induces apoptosis in the human ovarian cancer SKOV3 cell line","volume":"11","author":"Liu","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1111\/cas.14350","article-title":"Expression of long noncoding RNAs in cancer-associated fibroblasts linked to patient survival in ovarian cancer","volume":"111","author":"Colvin","year":"2020","journal-title":"Cancer Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.omto.2020.05.009","article-title":"Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1\/PD-L1 for Treating Pancreatic Cancer","volume":"17","author":"Yang","year":"2020","journal-title":"Mol. Ther. - Oncolytics"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/19\/10201\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:03:20Z","timestamp":1760166200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/19\/10201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":47,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["ijms221910201"],"URL":"https:\/\/doi.org\/10.3390\/ijms221910201","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]}}}